FGFR-2 and -3 play an important role in initial stages of oral oncogenesis

Anticancer Research

Volumn 26, Issue 6 B, 2006, Pages 4217-4221

  Vairaktaris, Eleftherios ^a   Ragos, Vassilis ^a   Yapijakis, Christos ^a   Derka, Spyridoula ^a   Vassiliou, Stavros ^a   Nkenke, Emeka ^b   Yannopoulos, Athanassios ^a   Spyridonidou, Sofia ^a   Vylliotis, Antonis ^a   Papakosta, Veronica ^a   Loukeri, Sofia ^a   Lazaris, Andreas ^a   Tesseromatis, Christina ^a   Tsigris, Christos ^a   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

FGFR 2; FGFR 3; Hamster; Histological grade; Immunohistochemistry; Oral squamous cell carcinoma

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2 ANTIBODY; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 3 ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; HISTOPATHOLOGY; MALE; MOUTH CANCER; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CRICETINAE; IMMUNOHISTOCHEMISTRY; MALE; MESOCRICETUS; MOUTH NEOPLASMS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3;

EID: 33845924114     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Das BR and Nagpal JK: Understanding the biology of oral cancer. Med Sci Monit 8: 258-267, 2002.
2. Sudbo J: Novel management of oral cancer: a paradigm of predictive oncology. Clin Med Res 2(4): 233-242, 2004.
3. Sudbo J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Soland TM and Lippman SM: Molecular based treatment of oral cancer. Oral Oncol 39: 749-758, 2003.
4. Dailey L, Ambrosetti D, Mansukhani A and Basilico C: Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 16: 233-247, 2005.
5. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 103: 211-225, 2000.
6. Givol D and Yayon A: Complexity of FGF receptors; genetic basis for structural diversity and functional specifity. FASEB J 6: 3362-3369, 1992.
7. Grose R and Dickson C: Fibroblast growth factor signalling in tumourigenesis. Cytokine Growth Factor Rev 16: 179-186, 2005.
8. Papakosta V, Vairaktaris E, Vylliotis A, Derka S, Nkenke E, Vassiliou S, Lazaris AC, Mourouzis C, Rallis G, Spyridonidou S, Anagnostopoulou S, Perrea D, Donta I, Yapijakis C and Patsouris E: The co-expression of c-myc and p53 increases and reaches a plateau in early stages of oral oncogenesis. Anticancer Res 26(4B): 2957-2962, 2006.
9. Chang KW, Saraj S, Lin SC, Tsai PI and Solt D: p53 expression p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 21(7): 1441-1451, 2000.
10. Balasenthil S, Saroja M, Ramachandran CR and Nagini S: Humans and hamsters: comparative analysis of lipid peroxidation, glutathione and glutathione-dependent enzymes during oral carcinogenesis. Br J Oral Maxillofac Surg 38: 267-270, 2000.
11. Derka S, Vairaktaris E, Papakosta V, Vassiliou S, Acil Y, Vylliotis A, Spyridonidou S, Lazaris AC, Mourouzis C, Kokkori A, Moulavassili P, Perrea D, Donta I, Yapijakis C and Patsouris E: Cell proliferation and apoptosis culminate in early stages of oral oncogenesis. Oral Oncol 42(5): 540-550, 2006.
12. Vairaktaris E, Papakosta V, Derka S, Vassiliou S, Nkenke E, Spyridonidou S, Vylliotis A, Lazaris AC, Kokkori A, Moulavassili P, Loukeri S, Perrea D, Donta I, Yapijakis C and Patsouris E: H-ras and c-fos exhibit similar expression patterns during oral oncogenesis. Acta Odontol Scand, 2006 (in press).
13. Wakulich C, Jackson-Boeters L, Daley TM and Wysocki GP: Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93: 573-579, 2002.
14. Forootan SS, Ke, Y, Jones AS and Helliwell TR: Basic fibroblast growth factor and angiogenesis in squamous cell carcinoma of the tongue. Oral Oncol 36: 437-443, 2000.